Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3978970 | Bulletin du Cancer | 2012 | 7 Pages |
Abstract
Prognostic signification of micrometastases ou isolated tumor cells (ITC) has not yet been clearly precised. Management of the axilla in case of micrometastases or ITC depends on the local pratices: no surgical completion or axillary lymph node dissection (ALND). Axillary lymph node status is the most important prognostic factor in patients with breast cancer; morbidity of ALND is now well known whereas its therapeutic benefit has not been demonstrated. This study is based on a retrospective database of 1375 patients who underwent sentinel node (SN) biopsy for breast cancer. In case of micrometastase or ITC in SN with completion axillary dissection, we examined if non-sentinel lymph node status has changed the indications of adjuvant treatments (chimiotherapy or radiotherapy). The results of our study show that non-sentinel lymph node status modify systemic therapy for a very few patients (less than 4% concerning chimiotherapy and less than 15% concerning radiotherapy).
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Caroline Schmitt, Catherine Bouteille, Christelle Faure, Hervé Mignotte, Olivier Tredan, Thomas Bachelot, Jean-Paul Guastalla, Antoine Arnaud, Isabelle Treilleux, Nicolas Carrabin,